Prospera Financial Services’s Trillium Therapeutics Inc. TRIL Stock Holding History

Prospera Financial Services’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-18,625	Closed	-$327K	–	919
2021 Q3	$327K	Buy	18,625 +6,264	+51%	+$73.2K	0.02%	640
2021 Q2	$120K	Buy	+12,361	New	+$116K	0.01%	777

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Prospera Financial Services's TRIL Position: Q4 2021 in Review

Prospera Financial Services sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 18,625 shares — an estimated $327K sold.

Prospera Financial Services first reported a position in TRIL in Q2 2021 and held it in 2 quarters. The position peaked at $327K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Prospera Financial Services reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Prospera Financial Services sold 18,625 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $327K.
Prospera Financial Services first reported a position in Trillium Therapeutics Inc. in Q2 2021 and held it in 2 quarters.
Prospera Financial Services's Trillium Therapeutics Inc. position peaked at $327K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Prospera Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.